TNYA

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) is a biotechnology company founded in 2016 and headquartered in South San Francisco, California. The company went public in July 2021 and focuses on developing innovative therapies for heart disease through three distinct technological platforms: cellular regeneration, gene therapy, and precision medicine. Since its inception, Tenaya has been dedicated to addressing the significant unmet medical needs in cardiovascular medicine, particularly targeting genetic forms of heart disease that currently have limited treatment options.